{"name":"Actinogen Medical","slug":"actinogen-medical","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Xanamem","genericName":"Xanamem","slug":"xanamem","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Xanamem","genericName":"Xanamem","slug":"xanamem","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-02-27","type":"pipeline","source":"simplywall.st","summary":"Actinogen Medical H1 2026 Wider A$17.9m TTM Loss Reinforces Bearish Narratives - simplywall.st","headline":"Actinogen Medical H1 2026 Wider A$17.9m TTM Loss Reinforces Bearish Narratives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxObGJzSnNFWkdXNzRmTDRwMXBpclBoaG1qbFRpOElfY1ZuMDU4YTJBUmxldEpkcG5tUmVaY0N1V3BwWG5rLWZjQ2ZzWFRXRmxJQjRsSEVJU21tblhXTWpYcFZEckY5b1FyQXRHNDhEWVNWQ3ZKY0VzNjVyWUVBVWk2RXhGM2VfRnBsQ3U2VlZobHR1aE9yUVVqbmptQ2p4bS0xenp4M3JDOTN3SmNzZVprbGlYSzR3cUJ6b2tfbmdnLU1XU0RGaVhVNWdxX3RGLTZtM1E?oc=5","date":"2026-02-01","type":"pipeline","source":"TipRanks","summary":"Actinogen Medical Launches Securities Purchase Plan for Up to 119 Million New Shares - TipRanks","headline":"Actinogen Medical Launches Securities Purchase Plan for Up to 119 Million New Shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQT3Z6cjRRemNTOXpmMjNBNE5BTGRiaEZ0b05PSDIxVGRrbDVJdTNVZzhuYnNaUFlTeVE3Y05mUk13MkJPcHQ1dVZsZ1RERWFKMi1IS2ljUnZVOGI5NnpFSGhHY0piSDZHMzU2aTZTQ0d1dDBUUVdfMnY2MDU0V09JclZSVlZfdjMzWEszVUpEcXAyMkxMNWJKc1JVY2hFckc1dU4w?oc=5","date":"2026-01-05","type":"pipeline","source":"Stockhead","summary":"The year that was – ASX healthcare analysts reflect on a volatile 2025 - Stockhead","headline":"The year that was – ASX healthcare analysts reflect on a volatile 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNUEJWX0tFY19HMndnN0E5NmU4NlB2NjlQdFM5MVg5ZTFKdWtyUzIxVWlwNjFlNDRNOHN6MkZoaHZTRE9vUWtRa2JKaG5fdXJBdTJKVGdrX3FFdzJHVVZmdXZEODRHVEl2XzlWTDlfVzN1MW1YM0FWRG5NZHh0MnVpSUpkWXVicDl4NXRRa0Z6TDNwVkZBNXdiYTEwQkdGcmVnY2R3aXhHc0ZSams5ZU02bE1IQjFKdw?oc=5","date":"2025-11-03","type":"pipeline","source":"Biotech Dispatch","summary":"Actinogen Medical presents Alzheimer’s and depression program at BIO-Europe 2025 - Biotech Dispatch","headline":"Actinogen Medical presents Alzheimer’s and depression program at BIO-Europe 2025","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-02","type":"pipeline","source":"simplywall.st","summary":"Companies Like Actinogen Medical (ASX:ACW) Are In A Position To Invest In Growth - simplywall.st","headline":"Companies Like Actinogen Medical (ASX:ACW) Are In A Position To Invest In Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNZm12dDMzLTZ3eHdkZlFIY0RNdVhWYmw5N0szRWpqWVl2Q1AtLUxLS3VNT2RxcHZZSngxZnRBMThuT1ktMEVBTGxvcmlaX0dtMnA4MEROZDlva3dIYl8tMV90dExCMXZncGZQWk5pR1NQVmFkTHBfN29jWlJPcmhWLW1jcEZabjJBSUt6S2djRUgyTkl3VHFZVHk5dlZjRU10SlNHM1NLUkgtNFhBajRpUzFFbEs4UzNsRTRPSHF5dUVyLTBYaWk4SnIzZUx2TFJxNm9iOXkteHc2aFJ6c1NZ?oc=5","date":"2025-02-06","type":"pipeline","source":"BioPharma APAC","summary":"WHO Grants ‘Emestedastat’ as the Official INN for Actinogen’s Xanamem®, a First-in-Class Cortisol Regulator - BioPharma APAC","headline":"WHO Grants ‘Emestedastat’ as the Official INN for Actinogen’s Xanamem®, a First-in-Class Cortisol Regulator","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNeDV0YWR3TTBkcmtaN1RBVVVvZ0FnNFhkU3dlcUp3R1NJM0d0a2FtYXJEUDFlNTk2UHRESzRMY2o1bXdKbHctR2lRZzJ1Q181ZHVTdjJienZuTW9ObUp3OXhoc0ZMTTFUWG5wRjFBaXFlODItMWxHVTYyMmlFeDctSjNRVnhaQUJlYWNaQjh0VlZqLWJfck8yUHRGaDNCT1V0R1NweFQ0bHl4VVJnWXVqZ0dRODJtbThkNFdoLU9JSjVZLWc5RU4wS051NjZhUmE5YUc3Tg?oc=5","date":"2025-02-05","type":"pipeline","source":"PR Newswire","summary":"Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem - PR Newswire","headline":"Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPeEdlZ1d4ZWFFdTNuREt2TlFZTHE5UmhrLTRGR09aZjd2czFkM294RkY0N0c4Rl9LWC02akVDMXdUS00tcU0weFZ5eFQ3RGpnMUdkQXMwVWpJOEJ2UWRKX2pJZXZxSkxNSVRKajhwaUJFVXBWazh2NlBWaFJOQWp1MTJNdTRPVWFGVVZ6YVl4NnExNHdfWGVfRGJYejNoZEk2Z2NQdUFSTFNxcDRYaGVYZWZTU3VjN1NLMG0zM05hSmpVME1nUFZnTEViSQ?oc=5","date":"2024-12-10","type":"trial","source":"BioPharma APAC","summary":"Actinogen Expands Alzheimer’s Trial Across Australia and US, Eyes Interim Results in 2025 - BioPharma APAC","headline":"Actinogen Expands Alzheimer’s Trial Across Australia and US, Eyes Interim Results in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxON2pIZlZ6T3YyS3FrMkFoQllpMnUtLUo0OFdJTmNRS01PeWFYSzBjel9OSjdDd2lOcUExenhNOWJ1UEVFRzMzZllLZktEdDZZSnJ4UGt6ZFg0MnI3dUo3M1JCOFZ6al9lczFSWDlTeVhRS28zem9uLXZRZHQybVJvUkZrd3Z2MUZRcDFkd3A3YTNFVTM2Yjg0djJ2NXNEZGxvX1VDbTR2RHE4MTdJekJjWU9IRDdFWDFNTFZKQjR0TW96SWtvQUZkcDAyc0ZIaTFRVFNnbFVPVC1ldFE?oc=5","date":"2024-12-09","type":"trial","source":"PR Newswire","summary":"Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial - PR Newswire","headline":"Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer's disease trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOaF9pNVBBa01lSHJ0VHZIZ0hYek1oMDhjZVBTcnBaS3ZTZUswamMwc19XRTV3ZE52ZjkyM0s3Vmc1U0NMblFjaTVIYzM2VnhmZXc5dmpDQjB2MGhFXzBWVG5waHJFdDJIMUx2X2F6NWowZTdZc2Q0U05mNEVUTWdBWVhnM192LWNQeDhEQ3p5N1VnNUd6Mmxja2szcXFTN1BYZ0hzb3laSDhGSlRIY0pZeHJBd1UyVHZZaVVGTVZDZw?oc=5","date":"2024-08-12","type":"trial","source":"Fierce Biotech","summary":"Australian biotech's cortisol blocker fails to improve attention in phase 2 depression study - Fierce Biotech","headline":"Australian biotech's cortisol blocker fails to improve attention in phase 2 depression study","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOZUwyNTE0cDRPZ0QtRC0yRzBaa0FGTlpQVDJwTHMzbWZjVWl2Z3lkU0c4YnB2UXVJR3pSY2s5dEFVTXI2MWRFZ2dMalZPV0RYVFZFelBLT01XVWE4R0FfOGZPMm1KcXZJR2RRcTBDZWtwQktkdFg2R2lRUXBqVTRncFRMX0JzLVdRSE1VZ3dCbEVOLW8xTU5KOTRxVFZSVlRIZ2puTGRaQV9oS1FrMl9zVXR2NGVNd09YY1hkbU0wM1paZmhiUEE?oc=5","date":"2023-07-07","type":"pipeline","source":"reuters.com","summary":"Companies in Alzheimer's race after US nod for Eisai/Biogen drug - reuters.com","headline":"Companies in Alzheimer's race after US nod for Eisai/Biogen drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE5YSDFtOUtpenZkQkVqRUZXX3NHQVFFSHdaSDdQMUdYRENSQWgyWEQ1SW9SeDMwek5hSWtzXzNoV3MwZUMyS3Y5WmZZTUpCbS1xV2lCelVnRGx5OHFzTk1LU0NqR1FqWEpZU3ROYno1ZmctQQ?oc=5","date":"2021-09-26","type":"pipeline","source":"Proactive financial news","summary":"Actinogen Medical Ltd Share Price - ACW, RNS News, Articles, Quotes, & Charts (ASX:ACW) - Proactive financial news","headline":"Actinogen Medical Ltd Share Price - ACW, RNS News, Articles, Quotes, & Charts (ASX:ACW)","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}